The influenza testing market finds applications in clinical diagnostics, aiding healthcare professionals in identifying and managing influenza infections. It is also instrumental in epidemiological surveillance, helping to monitor and control outbreaks. Molecular tests, such as PCR and real-time PCR, dominate the segment due to their high sensitivity, specificity, and ability to detect multiple influenza strains accurately. They offer precise diagnostic results and are widely employed in clinical and laboratory settings, particularly during flu seasons and pandemics.
According to Data Bridge Market Research, the Global Influenza Testing Market to grow at a CAGR of 8.4% in the forecast period of 2022-2029.
“Growing incidence of influenza diseases boost the market’s growth”
The growing incidence of influenza diseases is a significant driver for the influenza testing market. As the number of influenza cases increases, healthcare providers and governments prioritize testing to diagnose and manage outbreaks effectively. This heightened awareness and demand for accurate and rapid diagnostic solutions, along with the need for surveillance and early intervention, propel the market's growth. The ongoing research and development of innovative testing methods further contribute to the market's expansion to combat the influenza burden effectively.
What restraints the growth of the global influenza testing market?
“Stringent regulatory framework restraints the market’s growth”
A stringent regulatory framework poses a restraint in the influenza testing market. Regulatory agencies require thorough validation and approval processes for diagnostic tests, which can be time-consuming and costly for manufacturers. This can delay the introduction of new testing methods and products to the market. Additionally, compliance with evolving regulations necessitates ongoing investments in research and development. While regulations are essential for patient safety, they can hinder market growth by creating barriers to new entrants and innovation.
Segmentation: Global Influenza Testing Market
The global influenza testing market is segmented on the basis of product, test type, type of flu and end user.
- On the basis of product, the market is segmented into point-of-care testing, immunodiagnostics, and molecular diagnostics.
- On the basis of the test type, the influenza testing market has been segmented into traditional diagnostic tests and molecular diagnostic tests. Traditional diagnostic tests are further segmented into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. Molecular diagnostic tests are further segmented into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAM), simple amplification-based assays (SAMBA), and other molecular diagnostic tests.
- On the basis of type of flu, the influenza testing market has been segmented into type A flu, type B flu, and type C flu.
- On the basis of end user, the influenza testing market has been segmented into hospitals/clinical laboratories, reference laboratories, and other end users.
Regional Insights: North America dominates the Global Influenza Testing Market
North America's dominance in the influenza testing market can be attributed to the substantial market share held by the United States. The region is poised for further growth during the forecast period (2022-2029) due to the recurring incidence of influenza and the presence of advanced healthcare facilities. The combination of a sizable market and well-established healthcare infrastructure positions North America as a key player in driving the demand for influenza testing products and services.
The Asia-Pacific influenza testing market is set for substantial and rapid growth in the forecast period due to escalating demand for advanced diagnostic technologies in the region. Factors driving this demand include increasing healthcare infrastructure, rising awareness about influenza, and a growing patient population. As healthcare standards improve and diagnostic technologies become more accessible, the Asia-Pacific market is poised to become increasingly lucrative for influenza testing, meeting the region's healthcare needs effectively.
To know more about the study visit, https://www.databridgemarketresearch.com/es/reports/global-influenza-testing-market
Recent Developments
- In March 2021, Luminex Corporation took a significant step by submitting an Emergency Use Authorization (EUA) application to the US Food and Drug Administration (FDA) for its innovative multi-analyte respiratory panel. This panel covers various respiratory pathogens, including influenza A/B, respiratory syncytial virus (RSV), and SARS-CoV-2, allowing for simultaneous detection and diagnosis. The EUA application reflects Luminex's commitment to combating respiratory diseases and enhancing diagnostic capabilities in a crucial healthcare context.
The Prominent Key Players Operating in the Global Influenza Testing Market Include:
- Abbott (U.S.)
- BD (U.S.)
- CorisBioconcept (Belgium)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Luminex Corporation (U.S.)
- Meridian Life Science (U.S.)
- Quidel Corporation (U.S.)
- Sekisui Diagnostics (U.S.)
- Thermo Fisher Scientific (U.S.)
- Analytik Jena GmbH (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- bioMérieux SA (France)
- Cepheid (U.S.)
- GenMark Diagnostics, Inc. (U.S.)
- Danaher (U.S.)
- SA Scientific Ltd. (U.S.)
- QIAGEN (Germany)
- BODITECH MED INC. (South Korea)
Above are the key players covered in the report, to know about more and exhaustive list of global influenza testing market companies contact, https://www.databridgemarketresearch.com/es/contact
Research Methodology: Global Influenza Testing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
